Amphastar to quadruple domestic manufacturing
Expanded capacity adds to current fill and finish products already 100% manufactured in U.S.
Pharmacy
McKesson ideaShare allows independent pharmacies to innovate and thrive
Attendees fostered deeper connections and discovered new ways to strengthen their profession through three days of engaging sessions.
McKesson continues to roll with shifts in traditional retail pharmacy
Bresnahan pointed out that community pharmacy needs to diversify,“ to respond to the market shifts, [particularly] as traditional prescription volume starts to shift away from traditional retail pharmacy.”
Medicare drug price negotiation may harm generic and biosimilar development, warns report.
The paper concludes that, although the negotiation program might reduce drug costs initially, it could threaten the long-term sustainability of the generics and biosimilars market, a key driver of lower prescription costs.
Dave's Pharmacy earns 2025 Health Mart Pharmacy of the Year award
Dave’s Pharmacy delivers innovative clinical services—including point-of-care testing and remote patient monitoring—to elevate patient care.
Congressional leaders Carter and Harshbarger explain PBM Reform Act at ideaShare 2025
Buddy Carter is spearheading along with 11 bipartisan members of Congress, including Diana Harshbarger, in introducing the PBM Reform Act, which protects patients and pharmacies from the harmful and anticompetitive business practices of PBMs.
Sun Pharma launches Leqselvi for treatment of severe alopecia areata
With limited treatment options available to people living with severe alopecia areata in the U.S., the need for innovative therapies such as Leqselvi remains critically important.
Cardinal Health announces One Voice Initiative to support independent pharmacy advocacy
This investment furthers Cardinal Health's longstanding advocacy around the future of independent pharmacies and ongoing partnerships with industry organizations to support pharmacists' efforts to build relationships with elected officials at all levels of government.
NCPA: PBM Reform Act must pass ASAP
Systemic changes like those in the PBM Reform Act must pass and be enacted as soon as possible. We’re grateful for this bill’s introduction and will do everything we can to push it across the finish line.”
NACDS hails introduction of Pharmacy Benefit Manager Reform Act of 2025
The bill establishes powerful transparency requirements, bans spread pricing, assures fair reimbursement for pharmacies, and tackles anti-competitive practices that have driven up drug costs and limited patient choice.
Patent thickets and litigation abuses hinder all biosimilars
White paper analyzes problems and solutions to patent abuses.
Clover Health launches New Jersey Community Pharmacy Program in partnership with IPC’s iCare+ Network
The program will be anchored by IPC’s iCare+ Independent Pharmacy Network, which includes thousands of community-rooted pharmacies nationwide and many in New Jersey.
Merck to acquire Verona Pharma, expanding its portfolio to include Ohtuvayre
Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases.
Lupin launches ipratropium bromide nasal solution
Ipratropium bromide nasal solution (Nasal Spray), 0.03% and 0.06% are bioequivalent to Atrovent Nasal Spray, 0.03% and 0.06%, of Boehringer Ingelheim Pharmaceuticals.
Judge orders CVS’ Omnicare unit to pay $949M in fraud case
"This lawsuit centered on a highly technical prescription dispensing record keeping issue that was allowed by law in many states," CVS said in a statement.
Groups join the Biosimilars Council and AAM letter of support for interchangeability legislation
39 Groups support the Biosimilar Red Tape Elimination Act.